Speaking at CDMI Europe 2025, GlobalData pharma analyst George El-Helou says the use of AI in R&D could help mitigate patent ...

The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...

The Inflation Reduction Act (IRA) of 2022 Section 1193 states that when engaging in drug price negotiation, the Secretary of Health and Human Services should consider, among multiple factors, ...

The U.S. Capitol in Washington, DC. A bipartisan group of lawmakers has reintroduced legislation to allow immediate expensing of research and development costs, all the way back to 2022 when the tax ...

Two recent studies aimed to quantify how much R&D costs impact a drug’s price, and how much a drug’s effectiveness correlates with its price — factors that might, in theory, help justify a sizable ...

Research and development (R&D) productivity has long been a topic of concern amongst industry analysts (Drug Inf. J. 34, 1169–1194; 2000). In general, R&D productivity can be thought of as comprising ...

Steven Paul’s “How to improve R&D productivity: the pharmaceutical industry's grand challenge” published in Nature Reviews Drug Discovery in 2010 is one of the highest cited and most frequently quoted ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical R&D Outsourcing Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The Pharmaceutical R&D Outsourcing Market ...

Keysight Technologies reported notable sales growth for its fiscal third quarter, partly helped by customer interest in artificial intelligence (AI). But higher costs from newly escalated tariffs and ...

Skinner and Google are giving us a theoretical example of the “A1 Camera Company.” Skinner bids us assume its P&L shows $1 million in revenue and $600K in costs for a $400K operating profit — an ...